Physician profile
Kenneth Perret
NPI 1790701894
$12,468.99
in general payments reported to CMS, 2019-2025
34 companies · $1,758 in 2025
The $1,758 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $895 · 2020: $593 · 2021: $1,083 · 2022: $2,339 · 2023: $3,474 · 2024: $2,327 · 2025: $1,758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,875 · Travel and Lodging: $2,503 · Gift: $101 · Education: $79.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,874.92 |
| Travel and Lodging | $2,503.20 |
| Gift | $101.25 |
| Education | $79.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,770.45 | 2022-2024 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $1,945.25 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $966.29 | 2019-2025 | Nucala, Trelegy Ellipta, Shingrix |
| Genzyme Corporation | $921.33 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $777.65 | 2019-2025 | Ofev |
| Regeneron Healthcare Solutions, INC. | $515.78 | 2021-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $437.29 | 2019-2024 | |
| Mylan Specialty L.P. | $347.48 | 2019-2024 | Yupelri |
| Grifols USA, LLC | $299.97 | 2019-2025 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $284.41 | 2019-2024 | Opsumit, Uptravi |
| Takeda Pharmaceuticals U.S.A., INC. | $258.41 | 2023-2024 | Glassia, Cuvitru |
| Verona Pharma, INC. | $208.94 | 2025 | Ohtuvayre |
| Amgen INC. | $172.23 | 2022-2023 | Tezspire |
| Genentech USA, INC. | $170.09 | 2019-2025 | Xolair |
| Philips North America LLC | $165.95 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $162.54 | 2019-2025 | Arikayce |
| United Therapeutics Corporation | $150.08 | 2020-2025 | Tyvaso, Tyvaso |
| Paratek Pharmaceuticals, INC. | $125.00 | 2025 | Nuzyra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $117.75 | 2021 | |
| Merck Sharp & Dohme LLC | $102.68 | 2021-2025 | Winrevair, Recarbrio, Dificid |
| Inspire Medical Systems, INC. | $73.03 | 2023-2024 | Inspire |
| Covidien LP | $56.32 | 2020 | |
| Vifor Pharma, INC. | $51.64 | 2024-2025 | Zemaira |
| Tactile Systems Technology INC | $51.33 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Gilead Sciences, INC. | $50.10 | 2021 | |
| Viatris Specialty LLC | $47.83 | 2025 | Yupelri |
| Advanced Respiratory, INC | $41.68 | 2021 | |
| Pulmonx Corporation | $40.94 | 2021 | |
| Baxter Healthcare | $39.34 | 2024 | Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care |
| Fujifilm Healthcare Americas Corporation | $35.23 | 2024 | Fujifilm |
| Allergan, INC. | $34.57 | 2019 | |
| Pfizer INC. | $19.71 | 2025 | |
| Inogen, INC. | $19.16 | 2025 | |
| Veran Medical Technologies, INC. | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Perret listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.